For U.S. Residents Only
ABOUT ELIGARD
A Hormonal Therapy for The Management of
Advanced Prostate Cancer
IMPORTANT SAFETY IMFORMATION
Important Safety Information
ELIGARD should not be used by women, children, or anyone who is allergic to the
drug leuprolide acetate or any of the ingredients of ELIGARD. Leuprolide acetate
can cause harm to the fetus if given to a pregnant woman.
ELIGARD, like other drugs in its class, causes a temporary increase in testosterone
during the first and second weeks of treatment. Patients may experience worsening
of symptoms or new symptoms during the first weeks of treatment, including bone
pain, nerve damage, blood in the urine, pressure on the spine, or difficulty urinating.
If your cancer has spread to the spine or urinary tract, urinary blockage or pressure
in the spine may occur and can sometimes lead to paralysis, which may be fatal.
You may require close medical attention during the first few weeks of therapy and
you should notify your doctor if you develop any new or worsened symptoms after
beginning treatment with ELIGARD.
The most common injection site side effects are temporary burning and stinging,
pain, bruising and redness. The most common systemic adverse events include mild
to severe hot flashes/sweats, fatigue, weakness, fever, muscle pain, testicular
shrinkage and breast enlargement. For more information on these and other side effects,
please see table below and talk to your doctor.
Indication
ELIGARD is a prescription drug, given by injection, for the palliative treatment
(management of symptoms) of advanced prostate cancer. However, there is no known
cure for advanced prostate cancer.
Please see patient information
for important additional information.
|
Dose |
Systemic Side Effects |
ELIGARD
7.5 mg |
- Fatigue
- Dizziness
- Hot flashes/sweats
- Decrease in the size of the testes
- Inflammation of the stomach/intestine
|
ELIGARD
22.5 mg
|
- Hot flashes/sweats
- Fatigue
- Urinary frequency
- Nausea
- Itching
- Joint Pain
|
ELIGARD
30 mg |
- Hot flashes
- Fatigue
- Testicular atrophy (decrease in the size of the testes)
- Gynecomastia (breast growth)
- Testicular pain
- Clamminess
- Night sweats
- Hair loss
- Frequent need to urinate, especially at night
- Dizziness
- Decreased libido
- Myalgia (muscle pain)
- Nausea
|
ELIGARD
45 mg |
- Hot flashes
- Fatigue
- Weakness
- Testicular atrophy (decrease in the size of the testes)
- Gynecomastia (breast growth)
- Night sweats
- Myalgia (muscle pain)
- Pain in limb
|
Which best describes your hormonal therapy?
|
under the skin (subcutaneous) 0% |
|
directly into the muscle (intramuscular) 0% |
|
surgically implanted annually 0% |
|
not applicable 0% |
Important Safety Information
ELIGARD should not be used by women, children, or anyone who is allergic to the
drug leuprolide acetate or any of the ingredients of ELIGARD. Leuprolide acetate
can cause harm to the fetus if given to a pregnant woman.
ELIGARD, like other drugs in its class, causes a temporary increase in testosterone
during the first and second weeks of treatment. Patients may experience worsening
of symptoms or new symptoms during the first weeks of treatment, including bone
pain, nerve damage, blood in the urine, pressure on the spine, or difficulty urinating.
If your cancer has spread to the spine or urinary tract, urinary blockage or pressure
in the spine may occur and can sometimes lead to paralysis, which may be fatal.
You may require close medical attention during the first few weeks of therapy and
you should notify your doctor if you develop any new or worsened symptoms after
beginning treatment with ELIGARD.
The most common injection site side effects are temporary burning and stinging,
pain, bruising and redness. The most common systemic adverse events include mild
to severe hot flashes/sweats, fatigue, weakness, fever, muscle pain, testicular
shrinkage and breast enlargement. For more information on these and other side effects,
please talk to your doctor.
Indication
ELIGARD is a prescription drug, given by injection, for the management of advanced
prostate cancer. However, there is no known cure for prostate cancer.
Please see and full mixing and administration instructions.
Click here
for information on drug anti-counterfeiting.
| |
| |
| | | | |
